Search clinical trials for: Intravitreous injection of ranibizumab

Total 6648 results

Association for Innovation and Biomedical Research...
European Vision Institute Clinical Research Network

Completed

Prospective, Randomized, Multicentre, Open-label, Phase II / III Study to Assess Efficacy and Safety of Ranibizumab 0.5 mg Intravitreal Injections Plus Panretinal Photocoagulation (PRP) Versus PRP in Monotherapy in the Treatment of Subjects With High Risk Proliferative Diabetic Retinopathy. (PROTEUS)

High Risk Proliferative Diabetic Retinopathy

Portugal, Italy, United Kingdom, France
José Cunha-Vaz

Completed

Prospective, Randomized, Multicenter, Open Label, Phase II Study to Access Efficacy and Safety of Lucentis® Monotherapy Compared With Lucentis® Plus Panretinal Photocoagulation (PRP) and PRP in the Treatment of Patients With High Risk Proliferative Diabetic Retinopathy

High Risk Proliferative Diabetic Retinopathy

Portugal
Association for Innovation and Biomedical Research...

Completed

Prospective, Randomized, Open Label, Phase II Study to Assess Efficacy and Safety of Macugen® (Pegaptanib 0.3 mg Intravitreal Injections) Plus Panretinal Photocoagulation and PRP (Monotherapy) in the Treatment With High Risk PDR.

Diabetes Mellitus Type II | Diabetes Mellitus Type I | High Risk Proliferative Diabetic Retinopathy

Portugal
Beijing Tongren Hospital

Unknown

JY028 Single Vitreous Injection in a Phase 1 Clinical Trial in nAMD Patients

Macular Degeneration

China
Genentech, Inc.

Completed

A Study of the Efficacy and Safety of Ranibizumab Injection in Patients With Macular Edema Secondary to Branch Retinal Vein Occlusion (BRAVO) (BRAVO)

Macular Edema | Retinal Vein Occlusion
Genentech, Inc.

Completed

A Study of the Efficacy and Safety of Ranibizumab Injection in Patients With Macular Edema Secondary to Central Retinal Vein Occlusion (CRUISE) (CRUISE)

Macular Edema | Retinal Vein Occlusion
Peter A Campochiaro, MD
Genentech, Inc.

Completed

Ranibizumab (Lucentis) for Macular Edema Secondary to Vein Occlusions (LVO)

Macular Edema | Retinal Vein Occlusion

United States
Medical College of Wisconsin
University of Wisconsin, Milwaukee

Completed

Photobiomodulation for the Treatment of Diabetic Macular Edema (PTDME)

Diabetic Retinopathy

United States
Rajavithi Hospital

Completed

Intravitreal Aflibercept for Treatment of Polypoidal Choroidal Vasculopathy (PCV)

Symtomatic Macular Polypoidal Choroidal Vasculopathy

Thailand
Assistance Publique - Hôpitaux de Paris

Suspended

Treatment of the Bilateral Severe Uveitis by IVT of Regulator T-cells: Study of Tolerance of Dose (UVEREG)

Uveitis

France
Universidade Federal de Pernambuco

Completed

Effect of Dexamethasone on Reduction of Macular Thickness in Diabetic Patients, a Randomized Clinical Trial (EDRMT)

Diabetic Macular Edema

Brazil
Qena Faculty of medicine, South Valley University

Recruiting

Ranibizumab Versus Aflibercept for CRVO in Young Patients.

Non-Ischemic Central Retinal Vein Occlusion With Macular Edema

Egypt
Pusan National University Hospital
Novartis

Completed

Indocyanine Angiographic Changes of Choroidal Neovascularization by Ranibizumab

Exudative Age-related Macular Degeneration

Korea, Republic of
Vista Klinik

Completed

SD-OCT-guided Intravitreal Ranibizumab Treatment in Choroidal Neovascularization Due to Myopia

Age Related Macular Degeneration | Choroidal Neovascularization

Switzerland
New England Retina Associates

Completed

Lucentis as an Adjuvant Therapy With TTT-ICG Based in Choroidal Melanoma

Choroidal Melanoma

United States
St. Erik Eye Hospital

Unknown

Eylea and Lucentis for Macular Edema in Branch Retinal Vein Occlusion

Branch Retinal Vein Occlusion With Macular Edema

Sweden
Sohag University

Recruiting

Relationship Between Dyslipidemia and The Response of Diabetic Macular Edema to Intravitreal Injection of Anti Vascular Endothelial Growth Factor Agents

Diabetic Macular Edema

Egypt
Attila Vajas
Semmelweis University

Unknown

Safety and Efficacy of Intravitreal Ranibizumab as a Preoperative Adjunct Treatment Before Vitrectomy Surgery in Proliferative Diabetic Retinopathy (PDR) Compared to Vitrectomy Alone (VITARM)

Diabetic Retinopathy

Hungary
Novartis

Completed

Safety and Efficacy of Ranibizumab in Diabetic Macular Edema With Center Involvement (RESOLVE)

Diabetic Macular Edema

Switzerland
Federico II University

Completed

Evaluation of Retinal and Vascular Features in Coats Disease After Intravitreal Injections of Ranibizumab

Coats Disease

Italy
Instituto de Olhos de Goiania

Unknown

Ranibizumab for Myopic Neovascularization

Myopic Choroidal Neovascularization

Brazil
Genentech, Inc.

Recruiting

A Study Assessing Corneal Endothelial Cells in Patients With Neovascular Age-related Macular Degeneration Treated With the Port Delivery System With Ranibizumab (PDS) (Belvedere)

Neovascular Age-related Macular Degeneration

United States
Federico II University

Completed

OCTA and Polypoidal Choroidal Vasculopathy

Polypoidal Choroidal Vasculopathy

Italy
Fundació Institut Germans Trias i Pujol

Completed

Influence of the Vitreomacular Interface on the Progression of the Diabetic Macular Edema After Anti-VEGF Injection

Diabetic Macular Edema | Vitreomacular Interface | Anti-VEGF Treatment
Hawaii Pacific Health
Genentech, Inc.

Completed

Ranibizumab for Polypoidal Choroidal Vasculopathy (PCV) (PEARL)

Polypoidal Choroidal Vasculopathy

United States
Russian Academy of Medical Sciences

Unknown

Genetic Polymorphisms in Ranibizumab Treatment in Wet Age-Related Macular Degeneration (AMD)

Age-Related Macular Degeneration

Russian Federation
Ameera Gamal Abdelhameed

Completed

Intravitreal Ranibizumab in Recurrent ROP

Retinopathy of Prematurity

Egypt
Sun Yat-sen University

Terminated

Double-dose Ranibizumab for Polypoidal Choroidal Vasculopathy

Polypoidal Choroidal Vasculopathy

China
Instituto de Olhos de Goiania

Unknown

Bevacizumab Versus Ranibizumab in Age Related Macular Degeneration (AxL-2009)

Age Related Macular Degeneration

Brazil
Kantonsspital Aarau
University Hospital Inselspital, Berne

Completed

Lucentis to Treat Retinopathy of Prematurity (ROP) 3 Plus Disease

Retinopathy of Prematurity

Switzerland
University of Alexandria

Completed

Sub-macular Injection of Ranibizumab as a New Surgical Treatment for Refractory Diabetic Macular Edema

Diabetic Macular Edema
University of Sao Paulo
Fundação de Amparo à Pesquisa do Estado de São Paulo; Fundação de Apoio ao...

Unknown

Intravitreal Ranibizumab For Persistent New Vessels In Diabetic Retinopathy(Inipe Study) (INIPE)

Proliferative Diabetic Retinopathy
Qilu Pharmaceutical Co., Ltd.

Completed

Evaluating of the Safety, Pharmacokinetics and Pharmacodynamics of QL1205 and Lucentis® in Patients With Wet AMD

Wet Age-related Macular Degeneration

China
University Hospital, Bonn
Novartis

Completed

Ranibizumab to Treat Choroidal Neovascularization (CNV) in Patients With Pseudoxanthoma Elasticum (PXE)

Choroidal Neovascularization

Germany
University Hospital, Bonn
Novartis

Completed

Ranibizumab to Treat Type 2 Idiopathic Macular Telangiectasia (RAMA-Trial)

Type 2 Idiopathic Macular Telangiectasia

Germany
Pacific Eye Associates
Genentech, Inc.

Completed

Lucentis for Age-related Macular Degeneration Pigment Epithelial Detachments (DETAIL)

Age-related Macular Degeneration | Wet Macular Degeneration | Pigment Epithelial Detachment | Neovascular Macular Degeneration

United States
Southeast Clinical Research Associates, LLC
Genentech, Inc.

Completed

Efficacy of Biweekly Ranibizumab (0.5 mg) for Exudative Macular Degeneration Retinal Edema Refractory to Anti-VEGF

Exudative Age Related Macular Degeneration

United States
Ruijin Hospital

Recruiting

Phacoemulsification Combined With Intravitreal Injection of Ranibizumab Prevent Postoperative Capillary Non-perfusion Zone Progress in Non-proliferative Diabetic Retinopathy

Diabetic Retinopathy | Cataract Diabetic | Mild Non-proliferative Diabetic Retinopathy

China
Retina Research Foundation

Completed

Scotoma Reduction in AMD Patients Treated With Ranibizumab (SALVAGE)

Macular Degeneration

United States
Barnes Retina Institute
Massachusetts Eye and Ear Infirmary; Long Island Vitreoretinal Consultants; Illinois... and other collaborators

Completed

Bevacizumab Versus Ranibizumab in Treatment of Macular Edema From Vein Occlusion (CRAVE)

Macular Edema | Retinal Vein Occlusion

United States
Hospital Regional de São José - Dr. Homero de Miranda...

Unknown

Use of Intravitreal Ranibizumab in the Treatment of Vitreous Hemorrhage

Diabetic Retinopathy | Vitreous Hemorrhage

Brazil
Hoffmann-La Roche

Active, not recruiting

This Study Will Evaluate the Efficacy, Safety, and Pharmacokinetics of the Port Delivery System With Ranibizumab in Participants With Diabetic Macular Edema Compared With Intravitreal Ranibizumab (Pagoda)

Diabetic Macular Edema

United States
Shanghai Biomabs Pharmaceutical Co., Ltd.

Completed

Phase I Study to Compare CMAB818 Injection and Lucentis® in Patients With Wet AMD

Wet Age-related Macular Degeneration

China
Novartis Pharmaceuticals

Completed

Efficacy and Safety of Lucentis® (Ranibizumab Intravitreal Injections) in Chilean Patients With Diabetic Macular Edema.

Retinal Vein Occlusion | Age Related Macular Degeneration

Chile
Dongyang People's Hospital

Recruiting

Manage Macular Cystoid Edema With Retinal Vein Obstruction Using Traditional Chinese Medicine and Ranibizumab (JQMMT+RA)

Macular Cystoid Edema

China
New England Retina Associates

Withdrawn

Ranibizumab as a Rescue Therapy for Diabetic Macular Edema

Diabetic Macular Edema

United States
University Hospital Muenster
Novartis

Completed

Intravitreal Ranibizumab in Retinal Pigment Epithelial Detachments

Pigment Epithelial Detachment

Germany
Manhattan Eye, Ear & Throat Hospital
Genentech, Inc.

Completed

Treatment of Exudative and Vasogenic Chorioretinal Diseases Including Variants of AMD and Other CNV Related Maculopathy (FVF4140S)

Polypoidal Choroidal Vasculopathy | Pseudoxanthoma Elasticum | Pathological Myopia | Retinal Angiomatous Proliferation | Coats' Disease | Idiopathic Retinal Telangiectasia | Multi-focal Choroiditis | Rubeosis Iridis | Von Hippel Lindau Disease | BEST VITELLIFORM MACULAR DYSTROPHY, MULTIFOCAL (Disorder)

United States
University of Giessen
University of Leipzig

Recruiting

Combination of Ranibizumab and Targeted Laser Photocoagulation (CoRaLaII)

Central Retinal Vein Occlusion With Macular Edema

Germany
Ural State Medical University
Ural Institute of Cardiology; De Haar Research Foundation

Terminated

Ranibizumab and the Risk of Arterial Thromboembolic Events (RATE)

Coronary Artery Disease | Cerebrovascular Disorders | Age-related Macular Degeneration

Netherlands, Russian Federation

Search clinical trials for: Intravitreous injection of ranibizumab

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Brazil

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations